- Home
- SCYX vs CCM Comparison
SCYX vs CCM Comparison
Compare SCYX & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- CCM
- Stock Information
- Founded
- SCYX 1999
- CCM 1997
- Country
- SCYX United States
- CCM China
- Employees
- SCYX N/A
- CCM N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- SCYX Health Care
- CCM Health Care
- Exchange
- SCYX Nasdaq
- CCM Nasdaq
- Market Cap
- SCYX 28.5M
- CCM 33.3M
- IPO Year
- SCYX 2014
- CCM 2009
- Fundamental
- Price
- SCYX $0.71
- CCM $5.25
- Analyst Decision
- SCYX
- CCM
- Analyst Count
- SCYX 0
- CCM 0
- Target Price
- SCYX N/A
- CCM N/A
- AVG Volume (30 Days)
- SCYX 142.0K
- CCM 1.9K
- Earning Date
- SCYX 08-07-2025
- CCM 04-25-2025
- Dividend Yield
- SCYX N/A
- CCM N/A
- EPS Growth
- SCYX N/A
- CCM N/A
- EPS
- SCYX N/A
- CCM N/A
- Revenue
- SCYX $2,630,000.00
- CCM $52,603,198.00
- Revenue This Year
- SCYX $463.61
- CCM N/A
- Revenue Next Year
- SCYX $310.80
- CCM N/A
- P/E Ratio
- SCYX N/A
- CCM N/A
- Revenue Growth
- SCYX N/A
- CCM N/A
- 52 Week Low
- SCYX $0.66
- CCM $3.80
- 52 Week High
- SCYX $2.29
- CCM $10.50
- Technical
- Relative Strength Index (RSI)
- SCYX 38.69
- CCM 33.93
- Support Level
- SCYX $0.67
- CCM $5.50
- Resistance Level
- SCYX $0.75
- CCM $5.68
- Average True Range (ATR)
- SCYX 0.04
- CCM 0.18
- MACD
- SCYX 0.00
- CCM 0.00
- Stochastic Oscillator
- SCYX 33.06
- CCM 21.79
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.